Related Experiment Video
Updated: Jul 19, 2026

05:30
Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules
Published on: August 16, 2011
Schistosomiasis vaccine:research to development.
1Coordinator of Strategic Research at the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, CH-1211 Geneva 27, Switzerland.
Parasitology Today (Personal Ed.)
|October 17, 2006
Summary
International experts convened to review schistosomiasis vaccine development progress. They aimed to consolidate global efforts and recommend future directions for creating a vital schistosomiasis vaccine.
Area of Science:
- Tropical medicine
- Vaccinology
- Parasitology
Background:
- Schistosomiasis remains a significant global health burden, necessitating effective control strategies.
- The development of a schistosomiasis vaccine is a key objective for disease eradication.
- Previous efforts have faced challenges, requiring coordinated international collaboration.
Purpose of the Study:
- To review the current status of schistosomiasis vaccine development.
- To consolidate international research efforts and progress.
- To formulate recommendations for future vaccine research and development.
Main Methods:
- Summary of deliberations from international meetings held in Cairo, Egypt (May 21-25, 1997).
- Review of existing scientific data and progress in schistosomiasis vaccine research.
- Expert consensus-building on critical issues and future strategies.
Main Results:
- Identification of key challenges and opportunities in schistosomiasis vaccine development.
- Consensus on the need for continued and intensified international collaboration.
- Outlined strategic recommendations for advancing vaccine candidates through the development pipeline.
Conclusions:
- Schistosomiasis vaccine development requires sustained global commitment and resource allocation.
- Strategic planning and collaborative research are crucial for overcoming existing hurdles.
- The reviewed efforts provide a roadmap for achieving a safe and effective schistosomiasis vaccine.
Related Concept Videos
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccinations
Overview
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...

